| # | Title | Journal | Year | Citations |
|---|
| 1 | Osteosarcoma Overview | Rheumatology and Therapy | 2017 | 317 |
| 2 | Review of Osteosarcoma and Current Management | Rheumatology and Therapy | 2016 | 289 |
| 3 | Juvenile Idiopathic Arthritis: Diagnosis and Treatment | Rheumatology and Therapy | 2016 | 148 |
| 4 | Psoriatic Arthritis and Burden of Disease: Patient Perspectives from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey | Rheumatology and Therapy | 2016 | 146 |
| 5 | Treatment with Biologicals in Rheumatoid Arthritis: An Overview | Rheumatology and Therapy | 2017 | 115 |
| 6 | Systemic Lupus Erythematosus (SLE) Therapy: The Old and the New | Rheumatology and Therapy | 2020 | 100 |
| 7 | Role of Human Leukocyte Antigens (HLA) in Autoimmune Diseases | Rheumatology and Therapy | 2018 | 99 |
| 8 | A Review of Recent Advances Using Tocilizumab in the Treatment of Rheumatic Diseases | Rheumatology and Therapy | 2018 | 97 |
| 9 | Treatment Outcomes with Biosimilars: Be Aware of the Nocebo Effect | Rheumatology and Therapy | 2017 | 95 |
| 10 | Rheumatoid Arthritis: The Impact of Mental Health on Disease: A Narrative Review | Rheumatology and Therapy | 2020 | 79 |
| 11 | Efficacy and Safety of Secukinumab 150 mg with and Without Loading Regimen in Ankylosing Spondylitis: 104-week Results from MEASURE 4 Study | Rheumatology and Therapy | 2018 | 73 |
| 12 | Understanding the Role of Interleukin-6 (IL-6) in the Joint and Beyond: A Comprehensive Review of IL-6 Inhibition for the Management of Rheumatoid Arthritis | Rheumatology and Therapy | 2020 | 73 |
| 13 | Randomized Crossover Comparison of Injection Site Pain with 40 mg/0.4 or 0.8 mL Formulations of Adalimumab in Patients with Rheumatoid Arthritis | Rheumatology and Therapy | 2016 | 65 |
| 14 | Worldwide, 3-Year, Post-Marketing Surveillance Experience with Tofacitinib in Rheumatoid Arthritis | Rheumatology and Therapy | 2018 | 62 |
| 15 | Clinical, Economic, and Humanistic Burden Associated With Delayed Diagnosis of Axial Spondyloarthritis: A Systematic Review | Rheumatology and Therapy | 2020 | 62 |
| 16 | Rituximab for Rheumatoid Arthritis | Rheumatology and Therapy | 2015 | 61 |
| 17 | First Real-World Insights into Belimumab Use and Outcomes in Routine Clinical Care of Systemic Lupus Erythematosus in Germany: Results from the OBSErve Germany Study | Rheumatology and Therapy | 2016 | 60 |
| 18 | Malignancy Incidence, Management, and Prevention in Patients with Rheumatoid Arthritis | Rheumatology and Therapy | 2017 | 58 |
| 19 | Autoimmunity and Inflammation Link to Cardiovascular Disease Risk in Rheumatoid Arthritis | Rheumatology and Therapy | 2020 | 54 |
| 20 | Safety and Efficacy of Tofacitinib in Patients with Active Psoriatic Arthritis: Interim Analysis of OPAL Balance, an Open-Label, Long-Term Extension Study | Rheumatology and Therapy | 2020 | 54 |
| 21 | Efficacy and Safety of Subcutaneous Secukinumab 150 mg with or Without Loading Regimen in Psoriatic Arthritis: Results from the FUTURE 4 Study | Rheumatology and Therapy | 2019 | 53 |
| 22 | Risk Associated with Cumulative Oral Glucocorticoid Use in Patients with Giant Cell Arteritis in Real-World Databases from the USA and UK | Rheumatology and Therapy | 2018 | 52 |
| 23 | Patient Perceptions of Unmet Medical Need in Rheumatoid Arthritis: A Cross-Sectional Survey in the USA | Rheumatology and Therapy | 2019 | 52 |
| 24 | Hypersensitivity to Orthopedic Implants: A Review of the Literature | Rheumatology and Therapy | 2017 | 51 |
| 25 | Discontinuation of Biologic Therapy in Rheumatoid Arthritis: Analysis from the Corrona RA Registry | Rheumatology and Therapy | 2017 | 51 |
| 26 | Spebrutinib (CC-292) Affects Markers of B Cell Activation, Chemotaxis, and Osteoclasts in Patients with Rheumatoid Arthritis: Results from a Mechanistic Study | Rheumatology and Therapy | 2020 | 49 |
| 27 | Nonmedical Switching From Originators to Biosimilars: Does the Nocebo Effect Explain Treatment Failures and Adverse Events in Rheumatology and Gastroenterology? | Rheumatology and Therapy | 2020 | 49 |
| 28 | Secukinumab: A New Treatment Option for Psoriatic Arthritis | Rheumatology and Therapy | 2016 | 47 |
| 29 | Mannitol Preserves the Viscoelastic Properties of Hyaluronic Acid in an In Vitro Model of Oxidative Stress | Rheumatology and Therapy | 2014 | 44 |
| 30 | Improving the Management of Psoriatic Arthritis and Axial Spondyloarthritis: Roundtable Discussions with Healthcare Professionals and Patients | Rheumatology and Therapy | 2017 | 44 |
| 31 | Efficacy of Tofacitinib for the Treatment of Psoriatic Arthritis: Pooled Analysis of Two Phase 3 Studies | Rheumatology and Therapy | 2018 | 43 |
| 32 | Assessing Disease Activity in Psoriatic Arthritis: A Literature Review | Rheumatology and Therapy | 2019 | 43 |
| 33 | Predictors, Risk Factors, and Incidence Rates of Psoriatic Arthritis Development in Psoriasis Patients: A Systematic Literature Review and Meta-Analysis | Rheumatology and Therapy | 2021 | 42 |
| 34 | Depression Risk in Patients with Rheumatoid Arthritis in the United Kingdom | Rheumatology and Therapy | 2017 | 41 |
| 35 | Topical Diclofenac, an Efficacious Treatment for Osteoarthritis: A Narrative Review | Rheumatology and Therapy | 2020 | 41 |
| 36 | Upadacitinib in Patients with Psoriatic Arthritis and Inadequate Response to Biologics: 56-Week Data from the Randomized Controlled Phase 3 SELECT-PsA 2 Study | Rheumatology and Therapy | 2021 | 41 |
| 37 | Psoriatic Arthritis: What is Happening at the Joint? | Rheumatology and Therapy | 2019 | 40 |
| 38 | Review Article: Is Wnt Signaling an Attractive Target for the Treatment of Osteoarthritis? | Rheumatology and Therapy | 2020 | 40 |
| 39 | Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison | Rheumatology and Therapy | 2018 | 39 |
| 40 | Chronic Disease and Self-Injection: Ethnographic Investigations into the Patient Experience During Treatment | Rheumatology and Therapy | 2017 | 38 |
| 41 | Obesity and Psoriatic Arthritis: A Narrative Review | Rheumatology and Therapy | 2020 | 38 |
| 42 | Ustekinumab in the Treatment of Psoriasis and Psoriatic Arthritis | Rheumatology and Therapy | 2015 | 37 |
| 43 | An Update on Treatment and Management of Pediatric Systemic Lupus Erythematosus | Rheumatology and Therapy | 2016 | 37 |
| 44 | Chronic Autoimmune Epithelitis in Sjögren’s Syndrome and Primary Biliary Cholangitis: A Comprehensive Review | Rheumatology and Therapy | 2017 | 37 |
| 45 | Understanding and Minimising Injection-Site Pain Following Subcutaneous Administration of Biologics: A Narrative Review | Rheumatology and Therapy | 2020 | 37 |
| 46 | A Review of the Prevalence and Unmet Needs in the Management of Rheumatoid Arthritis in Africa and the Middle East | Rheumatology and Therapy | 2021 | 35 |
| 47 | Adalimumab Biosimilars in the Treatment of Rheumatoid Arthritis: A Systematic Review of the Evidence for Biosimilarity | Rheumatology and Therapy | 2021 | 35 |
| 48 | bDMARD Dose Reduction in Rheumatoid Arthritis: A Narrative Review with Systematic Literature Search | Rheumatology and Therapy | 2017 | 34 |
| 49 | Real-World Patient Experience on the Path to Diagnosis of Ankylosing Spondylitis | Rheumatology and Therapy | 2019 | 32 |
| 50 | Non-Radiographic Axial Spondyloarthritis (nr-axSpA): Advances in Classification, Imaging and Therapy | Rheumatology and Therapy | 2019 | 32 |
